S3040

1) What happened and its current status: Senator Amy Klobuchar (D-MN) introduced S3040 on October 23, 2025, with one cosponsor (Senator Banks). The bill was read twice and referred to the Senate Committee on Veterans' Affairs. It is in early stage — no committee markup, no floor vote, no House companion. Related bill HR2034 is in the House but also at early stage. The bill expands the Edith Nourse Rogers STEM Scholarship by removing the requirement that veterans have less than 180 days of remaining GI Bill entitlement to qualify, and reducing the minimum credits completed from 60 to 45 (and from 90 to 67.5 for non-traditional programs). This allows more veterans to receive up to 9 additional months of benefits (capped at $30,000) for STEM and healthcare degrees. 2) The money trail: This bill does not authorize or appropriate new funding — it expands eligibility for an existing scholarship program funded through the Post-9/11 GI Bill. The $30,000 cap per recipient remains, and the scholarship uses existing VA entitlement. Actual spending depends on how many new veterans qualify and enroll. No new appropriations are required by this bill. The executive order on psychedelic therapies (April 18, 2026) is unrelated to this bill — it targets healthcare regulatory approval, not education funding. 3) Structural winners and losers: Primary beneficiaries are for-profit education companies with strong STEM and healthcare programs targeting adult learners: Stride ($LRN) and Perdoceo ($PRDO). These companies have flexible online models that appeal to veterans and can directly capture enrollment growth. Large tech employers (GOOGL, MSFT, AMZN) benefit structurally through improved workforce pipeline, but this is a small, long-term effect. Healthcare employers like UnitedHealth Group benefit from increased healthcare-degree graduates. Losers are negligible — this bill does not cut any programs. 4) Market data context: at $349.78 (near 52-week high of $353.18, 30-day +27.5%), at $429.25 (30-day +20.32%), at $259.70 (near 52-week high of $264.50, 30-day +30.28%) — all three are in strong uptrends driven by broader tech momentum. $LRN at $92.58 (7-day -9.26%, 30-day +8.14%) and $PRDO at $33.82 (7-day -6.34%, 30-day -9.16%) are showing recent weakness, which may create entry points as the legislative catalyst develops. at $366.77 (30-day +41.6%) is in a strong uptrend driven by broader healthcare sector momentum. 5) Timeline: The bill is early-stage — referred to committee in October 2025 with no further action. Passage probability is low in the near term (mid-2026 is an election year). If reintroduced in the 120th Congress (2027-2029), it would need to restart. Immediate market impact is minimal; the analysis is about structural positioning for the long-term trend of expanding veteran education benefits.